These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38506249)

  • 1. "Better at home": Mixed methods report of intricacies in pediatric febrile neutropenia management.
    Smeallie ET; Choi SW; Mody R; Guetterman TC; Nessle CN
    Cancer Med; 2024 Mar; 13(6):e7106. PubMed ID: 38506249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home-based care of low-risk febrile neutropenia in children-an implementation study in a tertiary paediatric hospital.
    Haeusler GM; Gaynor L; Teh B; Babl FE; Orme LM; Segal A; Mechinaud F; Bryant PA; Phillips B; Lourenco RA; Slavin MA; Thursky KA
    Support Care Cancer; 2021 Mar; 29(3):1609-1617. PubMed ID: 32740894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.
    Dommett R; Geary J; Freeman S; Hartley J; Sharland M; Davidson A; Tulloh R; Taj M; Stoneham S; Chisholm JC
    Eur J Cancer; 2009 Nov; 45(16):2843-9. PubMed ID: 19616427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia.
    Peters S; Adler M; Rossoff J
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e948-e952. PubMed ID: 37700440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
    Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.
    Delebarre M; Tiphaine A; Martinot A; Dubos F
    Pediatr Blood Cancer; 2016 Dec; 63(12):2167-2172. PubMed ID: 27569451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?
    Chen AY; Gottlieb M; Vilke GM; Coyne C
    J Emerg Med; 2023 Jan; 64(1):111-118. PubMed ID: 36641256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of febrile neutropenia in pediatric oncology across Queensland, Australia: a retrospective review on variations between locations.
    Cox A; Bradford N
    J Pediatr Oncol Nurs; 2014; 31(1):28-33. PubMed ID: 24378817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
    Delebarre M; Dessein R; Lagrée M; Mazingue F; Sudour-Bonnange H; Martinot A; Dubos F
    J Infect; 2019 Aug; 79(2):95-100. PubMed ID: 31228471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians.
    Haeusler GM; De Abreu Lourenco R; Bakos C; O'Brien T; Slavin MA; Clark JE; McMullan B; Borland ML; Babl FE; Krishnasamy M; Vanevski M; Thursky KA; Hall L
    J Paediatr Child Health; 2021 Jun; 57(6):826-834. PubMed ID: 33533525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia.
    Baugh CW; Faridi MK; Mueller EL; Camargo CA; Pallin DJ
    PLoS One; 2019; 14(5):e0216835. PubMed ID: 31120893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of home-based care of febrile neutropenia in children with cancer.
    Tew M; De Abreu Lourenco R; Gordon JR; Thursky KA; Slavin MA; Babl FA; Orme L; Bryant PA; Teh BW; Dalziel K; Haeusler GM
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29469. PubMed ID: 34854550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quest for certainty regarding early discharge in paediatric low-risk febrile neutropenia: a multicentre qualitative focus group discussion study involving patients, parents and healthcare professionals in the UK.
    Morgan JE; Phillips B; Stewart LA; Atkin K
    BMJ Open; 2018 May; 8(5):e020324. PubMed ID: 29764879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
    Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
    Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
    Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
    Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
    Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral magnesium supplementation in reducing febrile neutropenia episodes in children with solid tumors treated with cisplatin-based chemotherapy: randomized clinical trial.
    Castelán-Martínez OD; Palomo-Colli MA; Barrios-López VE; Silva-Jivaja KM; Juárez-Villegas LE; Castañeda-Hernández G; Sánchez-Rodríguez MA
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):673-679. PubMed ID: 33030582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.